Vitamin Shoppe (VSI) Upgraded by Zacks Investment Research to Hold

Vitamin Shoppe (NYSE:VSI) was upgraded by Zacks Investment Research from a “strong sell” rating to a “hold” rating in a research note issued on Sunday.

According to Zacks, “Vitamin Shoppe is a specialty retailer and direct marketer of nutritional products. It primarily sells vitamins, minerals, nutritional supplements, herbs, sports nutrition formulas, homeopathic remedies, green living products and health and beauty aids. Based in North Bergen, New Jersey, the company is recognized as an innovator in providing product information, associate training, and customer education. Information is available to consumers through unprecedented outlets including television, radio, friends, family, health practitioners, and the internet. It offers consumers the opportunity to take charge of their own health and wellness requirements, and supplement where necessary. At each store location, consumers can find a comprehensive Learning Center which offers free access to vital information about key health concerns and products. The Vitamin Shoppe is a strong supporter of health and wellness campaigns including Life Supplemented sponsored by the Council for Responsible Nutrition. “

A number of other brokerages also recently weighed in on VSI. ValuEngine upgraded Vitamin Shoppe from a “hold” rating to a “buy” rating in a report on Thursday, October 5th. Morgan Stanley reiterated an “equal weight” rating and set a $7.50 price target (down previously from $8.00) on shares of Vitamin Shoppe in a report on Monday, October 2nd. Finally, Barclays lowered their price target on Vitamin Shoppe from $6.00 to $3.00 and set an “equal weight” rating on the stock in a report on Thursday, November 9th. Three research analysts have rated the stock with a sell rating and six have issued a hold rating to the stock. Vitamin Shoppe has a consensus rating of “Hold” and an average price target of $5.00.

Vitamin Shoppe (NYSE:VSI) opened at $5.05 on Friday. Vitamin Shoppe has a twelve month low of $2.95 and a twelve month high of $23.25. The company has a current ratio of 2.07, a quick ratio of 0.32 and a debt-to-equity ratio of 0.59. The firm has a market capitalization of $121.08, a price-to-earnings ratio of 5.43 and a beta of 0.68.

Vitamin Shoppe (NYSE:VSI) last issued its quarterly earnings results on Wednesday, November 8th. The specialty retailer reported ($0.03) earnings per share for the quarter, missing analysts’ consensus estimates of $0.17 by ($0.20). Vitamin Shoppe had a negative net margin of 20.27% and a positive return on equity of 6.17%. The business had revenue of $288.20 million for the quarter, compared to analysts’ expectations of $297.61 million. During the same quarter in the prior year, the firm posted $0.50 EPS. The business’s quarterly revenue was down 8.5% compared to the same quarter last year. analysts expect that Vitamin Shoppe will post 0.34 EPS for the current fiscal year.

In other news, major shareholder Vintage Capital Management Llc acquired 326,692 shares of Vitamin Shoppe stock in a transaction that occurred on Friday, January 5th. The stock was purchased at an average price of $4.96 per share, with a total value of $1,620,392.32. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. In the last three months, insiders have purchased 694,839 shares of company stock valued at $3,214,809. Insiders own 1.07% of the company’s stock.

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Macquarie Group Ltd. acquired a new stake in Vitamin Shoppe during the third quarter valued at $101,000. BNP Paribas Arbitrage SA boosted its position in Vitamin Shoppe by 2.1% during the second quarter. BNP Paribas Arbitrage SA now owns 9,242 shares of the specialty retailer’s stock valued at $108,000 after purchasing an additional 192 shares during the last quarter. Wolverine Trading LLC acquired a new stake in Vitamin Shoppe during the second quarter valued at $131,000. UBS Asset Management Americas Inc. boosted its position in Vitamin Shoppe by 17,041.4% during the second quarter. UBS Asset Management Americas Inc. now owns 11,999 shares of the specialty retailer’s stock valued at $140,000 after purchasing an additional 11,929 shares during the last quarter. Finally, Dynamic Technology Lab Private Ltd boosted its position in Vitamin Shoppe by 72.7% during the second quarter. Dynamic Technology Lab Private Ltd now owns 17,761 shares of the specialty retailer’s stock valued at $207,000 after purchasing an additional 7,478 shares during the last quarter. 90.35% of the stock is owned by hedge funds and other institutional investors.

ILLEGAL ACTIVITY NOTICE: “Vitamin Shoppe (VSI) Upgraded by Zacks Investment Research to Hold” was first posted by American Banking News and is the property of of American Banking News. If you are accessing this piece on another publication, it was copied illegally and republished in violation of international copyright laws. The correct version of this piece can be viewed at https://www.americanbankingnews.com/2018/01/21/vitamin-shoppe-vsi-upgraded-by-zacks-investment-research-to-hold.html.

Vitamin Shoppe Company Profile

Vitamin Shoppe, Inc (VSI) is a multi-channel specialty retailer and contract manufacturer of vitamins, minerals, herbs, specialty supplements, sports nutrition, and other health and wellness products. The Company operates through three segments: retail, direct and manufacturing. The retail segment includes Vitamin Shoppe, Super Supplements and Vitapath retail store formats.

Get a free copy of the Zacks research report on Vitamin Shoppe (VSI)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for Vitamin Shoppe (NYSE:VSI)

Receive News & Ratings for Vitamin Shoppe Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitamin Shoppe and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply